Evidence for an interaction of neuronostatin with the orphan G protein-coupled receptor, GPR107.

Am J Physiol Regul Integr Comp Physiol

Department of Pharmacological and Physiological Science, Saint Louis Univ. School of Medicine, 1402 S. Grand Blvd., St. Louis, MO 63104, USA.

Published: November 2012

Neuronostatin, derived from the somatostatin preprohormone, is a recently described peptide that is produced by several tissues involved in cardiovascular regulation and metabolism, including the hypothalamus. Injection of neuronostatin into the lateral cerebroventricle led to a dose-related increase in mean arterial pressure (MAP) in rats. Any attempt to inhibit the production of neuronostatin would alter somatostatin production as well, making determination of the physiological relevance of the peptide's pharmacologic effects by compromise of production approaches impossible. Therefore, we employed an alternative approach to identify and compromise the production of the neuronostatin receptor. Because neuronostatin was shown to signal via a PKA-dependent mechanism, we hypothesized that the neuronostatin receptor was a G protein-coupled receptor (GPCR), in particular, one of the orphan GPCRs for which the ligand is unknown. Therefore, we screened neuronostatin-responsive tissues, including hypothalamus, heart, pancreatic α-cells, and the gastric tumor cell line KATOIII, for expression of orphan GPCRs. Four orphan GPCRs were expressed by all cell types, including GPR56 and GPR107. Knockdown of GPR107, but not GPR56 or GPR146, led to a loss of responsiveness to neuronostatin by KATOIII cells. Rats injected with siRNA directed against GPR107 (2 μg/day for 2 days) into the lateral cerebroventricle did not exhibit an increase in MAP in response to neuronostatin treatment. Rats with compromised GPR107 expression also displayed blunted reactivity in a baroreflex sensitivity test, indicating that GPR107 and neuronostatin may be important regulators of cardiovascular function. Thus, GPR107 is a promising candidate receptor for neuronostatin, and neuronostatin, interacting with GPR107, may play an important role in the central control of cardiovascular function.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3517703PMC
http://dx.doi.org/10.1152/ajpregu.00336.2012DOI Listing

Publication Analysis

Top Keywords

neuronostatin
12
orphan gpcrs
12
protein-coupled receptor
8
gpr107
8
gpr107 neuronostatin
8
including hypothalamus
8
lateral cerebroventricle
8
production neuronostatin
8
compromise production
8
neuronostatin receptor
8

Similar Publications

Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, which is characterized by the accumulation and aggregation of amyloid in brain. Neuronostatin (NST) is an endogenous peptide hormone that participates in many fundamental neuronal processes. However, the metabolism and function of NST in neurons of AD mice are not known.

View Article and Find Full Text PDF

Neuronostatin suppresses the differentiation of white preadipocytes. However, the role of neuronostatin in brown adipose tissue remains elusive. Therefore, we investigated the impact of neuronostatin on the proliferation and differentiation of isolated rat brown preadipocytes.

View Article and Find Full Text PDF

[The biological role of neuronostatin, a hormone encoded by the somatostatin gene].

Postepy Biochem

June 2023

Katedra Fizjologii, Biochemii i Biostruktury Zwierząt, Uniwersytet Przyrodniczy w Poznaniu.

Neuronostatin is a peptide hormone encoded by the somatostatin gene. Neuronostatin was discovered in 2008 using bioinformatics methods. Studies in rodents have shown that it exerts a widespread effects in the central nervous system, as well as in peripheral tissues.

View Article and Find Full Text PDF

Emerging functions of neuronostatin in physiology, pathology, and potential therapeutics.

Neuropeptides

August 2022

College of Life Sciences, Northwest Normal University, Lanzhou, Gansu 730070, China. Electronic address:

Neuronostatin, a bioactive peptide hormone, was encoded by pro-somatostatin and discovered using a bioinformatic method in 2008. Neuronostatin is widely expressed in the central nervous system (CNS) and peripheral tissues, it is also highly conserved among humans, rodents, and even goldfish. The 13 and 19 amino acids and the C-terminal amidation type play important roles in physiological and pathological functions.

View Article and Find Full Text PDF

MECHANISMS IN ENDOCRINOLOGY: The physiology of neuronostatin.

Eur J Endocrinol

September 2021

Center for Clinical Metabolic Research, Department of Medicine, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.

In 2008, the first evidence of a new hormone called neuronostatin was published. The hormone was discovered using a bioinformatic method and found to originate from the same preprohormone as somatostatin. This small peptide hormone of 13 amino acids and a C-terminal amidation was soon found to exert pleiotropic physiological effects.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!